CAS: 139308-65-9 - Tolafentrine
Fórmula:C28H31N3O4S
InChI:InChI=1/C28H31N3O4S/c1-18-5-11-21(12-6-18)36(32,33)30-20-9-7-19(8-10-20)28-23-16-27(35-4)26(34-3)15-22(23)24-17-31(2)14-13-25(24)29-28/h5-12,15-16,24-25,30H,13-14,17H2,1-4H3/t24-,25-/m0/s1
- Sinónimos:
- rel-(-)-N-[4-[(4aR,10bS)-1,2,3,4,4a,10b-Hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl]phenyl]-4-methylbenzenesulfonamide
- N-{4-[(4aS,10bR)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin-6-yl]phenyl}-4-methylbenzenesulfonamide
Benzenesulfonamide, N-[4-[(4aR,10bS)-1,2,3,4,4a,10b-hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl]phenyl]-4-methyl-, rel-(-)-
CAS:139308-65-9
Fórmula:
C28H31N3O4S
Forma y color:
Solid
Peso molecular:
505.6284
Ref: IN-DA001AQ2
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 8 de Enero de 2025
Ref: 4Z-T-137001
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 9 de Enero de 2025
Tolafentrine
Producto controladoCAS:139308-65-9
Applications A dual-selective phosphodiesterase 3/4 inhibitor used in chronic experimental pulmonary hypertension. References Huxtable, R., …
Fórmula:
C28H31N3O4S
Forma y color:
Neat
Peso molecular:
505.63
Ref: TR-T531000
2mg | 872,00 € | ||
5mg | 1.784,00 € | ||
500µg | 268,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Tolafentrine
CAS:139308-65-9
Tolafentrine is a drug used to treat chronic bronchitis and inflammatory bowel disease. It is …
Fórmula:
C28H31N3O4S
Pureza:
Min. 98 Area-%
Forma y color:
Powder
Peso molecular:
505.63 g/mol
Ref: 3D-FT28303
1mg | 986,00 € | ||
2mg | 1.392,00 € | ||
5mg | 2.551,00 € | ||
10mg | 4.637,00 € | ||
500µg | 582,00 € |
Entrega estimada en Estados Unidos, el Miércoles 19 de Febrero de 2025